Background: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the formation of fluid-filled cysts in the kidney and end stage renal disease by the fourth or fifth decade of life. Mutations in the PKD1 gene account for 85% of all cases of ADPKD. No curative therapy exists for patients affected by this disease and an underexplored avenue for the treatment of ADPKD is the targeting of epigenetic changes that occur during cystogenesis. Limited data exists on alterations in DNA methylation that are associated with ADPKD. Given the similarities between cyst growth and neoplasia, and the fact that 2 DNA methylation inhibitors are already Food and Drug Administration-approved for the treatment of myelodysplastic syndrome, we hypothesized that global DNA methylation patterns in ADPKD would parallel that observed in neoplasia, and which may provide an opportunity to treat ADPKD with epigenetic inhibitors. To address this hypothesis, we undertook a global DNA methylation analysis of human ADPKD kidney. Methods: We generated single nucleotide resolution methylomes of cortical kidney tissue from individuals with ADPKD, and from non-ADPKD kidney tissue, using reduced representation bisulfite sequencing. Using quantitative reverse transcription polymerase chain reaction, we investigated expression of the PKD1 gene in both ADPKD and non-ADPKD kidney. Results: We have shown that ADPKD-derived genomic DNA exhibits global hypomethylation when compared with non-ADPKD kidney, a pattern commonly observed in DNA methylation studies of tumor-derived tissue. We have also identified 13 discrete regions that are significantly differentially methylated in ADPKD compared to non-ADPKD, and 8 of these are gene specific. The PKD1 gene shows an increase in methylation at the 3′ end of the gene body, but in contrast to previously published data, this is not associated with a decrease in PKD1 mRNA expression. Conclusion: This genome-scale single nucleotide resolution analysis of DNA methylation in human polycystic kidneys suggests that DNA methylation differences at specific loci are associated with ADPKD. Further exploration into the significance of these preliminary results may shed light on the disease process, and potentially reveal new therapeutic possibilities.

Keywords:
Polycystic kidney, DNA methylation, PKD1, Autosomal dominant polycystic kidney disease, Reduced representation bisulfite sequencing
1.
Solazzo A, Testa F, Giovanella S, Busutti M, Furci L, Carrera P, Ferrari M, Ligabue G, Mori G, Leonelli M, Cappelli G, Magistroni R: The prevalence of autosomal dominant polycystic kidney disease (ADPKD): a meta-analysis of European literature and prevalence evaluation in the Italian province of modena suggest that ADPKD is a rare and underdiagnosed condition. PLoS One 2018; 13:e0190430.
2.
Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino GG: PKD1 interacts with pKD2 through a probable coiled-coil domain. Nat Genet 1997; 16: 179–183.
3.
Stayner C, Zhou J: Polycystin channels and kidney disease. Trends Pharmacol Sci 2001; 22: 543–546.
4.
Nauli SM, Zhou J: Polycystins and mechanosensation in renal and nodal cilia. Bioessays 2004; 26: 844–856.
5.
Cao Y, Semanchik N, Lee SH, Somlo S, Barbano PE, Coifman R, Sun Z: Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proc Natl Acad Sci U S A 2009; 106: 21819–21824.
6.
Li X: Epigenetics and autosomal dominant polycystic kidney disease. Biochim Biophys Acta 2011; 1812: 1213–1218.
7.
Woo YM, Bae JB, Oh YH, Lee YG, Lee MJ, Park EY, Choi JK, Lee S, Shin Y, Lyu J, Jung HY, Lee YS, Hwang YH, Kim YJ, Park JH: Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development. Hum Genet 2014; 133: 281–297.
8.
Woo YM, Shin Y, Hwang JA, Hwang YH, Lee S, Park EY, Kong HK, Park HC, Lee YS, Park JH: Epigenetic silencing of the mupcdh gene as a possible prognostic biomarker for cyst growth in ADPKD. Sci Rep 2015; 5: 15238.
9.
Jones PA: Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13: 484–492.
10.
Chatterjee A, Stockwell PA, Ahn A, Rodger EJ, Leichter AL, Eccles MR: Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis. Oncotarget 2017; 8: 6085–6101.
11.
Jia N, Wang J, Li Q, Tao X, Chang K, Hua K, Yu Y, Wong KK, Feng W: DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer. Oncotarget 2016; 7: 84785–84797.
12.
Guillaumet-Adkins A, Richter J, Odero MD, Sandoval J, Agirre X, Catala A, Esteller M, Prosper F, Calasanz MJ, Buno I, Kwon M, Court F, Siebert R, Monk D: Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels. J Hematol Oncol 2014; 7: 4.
13.
Seynnaeve B, Lee S, Borah S, Park Y, Pappo A, Kirkwood JM, Bahrami A: Genetic and epigenetic alterations of TERT are associated with inferior outcome in adolescent and young adult patients with melanoma. Sci Rep 2017; 7: 45704.
14.
Grantham JJ: Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 2008; 359: 1477–1485.
15.
Grantham JJ: Polycystic kidney disease: neoplasia in disguise. Am J Kidney Dis 1990; 15: 110–116.
16.
Chatterjee A, Ozaki Y, Stockwell PA, Horsfield JA, Morison IM, Nakagawa S: Mapping the zebrafish brain methylome using reduced representation bisulfite sequencing. Epigenetics 2013; 8: 979–989.
17.
Chatterjee A, Rodger EJ, Stockwell PA, Weeks RJ, Morison IM: Technical considerations for reduced representation bisulfite sequencing with multiplexed libraries. J Biomed Biotechnol 2012; 2012: 741542.
18.
Chatterjee A, Stockwell PA, Horsfield JA, Morison IM, Nakagawa S: Base-resolution DNA methylation landscape of zebrafish brain and liver. Genom Data 2014; 2: 342–344.
19.
Chatterjee A, Macaulay EC, Rodger EJ, Stockwell PA, Parry MF, Roberts HE, Slatter TL, Hung NA, Devenish CJ, Morison IM: Placental hypomethylation is more pronounced in genomic loci devoid of retroelements. G3 (Bethesda) 2016; 6: 1911–1921.
20.
Chatterjee A, Stockwell PA, Rodger EJ, Morison IM: Comparison of alignment software for genome-wide bisulphite sequence data. Nucleic Acids Res 2012; 40:e79.
21.
Krueger F, Andrews SR: Bismark: A flexible aligner and methylation caller for bisulfite-seq applications. Bioinformatics 2011; 27: 1571–1572.
22.
Stockwell PA, Chatterjee A, Rodger EJ, Morison IM: DMAP: differential methylation analysis package for rrbs and wgbs data. Bioinformatics 2014; 30: 1814–1822.
23.
Chatterjee A, Stockwell PA, Rodger EJ, Morison IM: Genome-scale DNA methylome and transcriptome profiling of human neutrophils. Sci Data 2016; 3: 160019.
24.
Chatterjee A, Stockwell PA, Rodger EJ, Duncan EJ, Parry MF, Weeks RJ, Morison IM: Genome-wide DNA methylation map of human neutrophils reveals widespread inter-individual epigenetic variation. Sci Rep 2015; 5: 17328.
25.
Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T, Rosen N, Kohn A, Twik M, Safran M, Lancet D, Cohen D: Genehancer: genome-wide integration of enhancers and target genes in genecards. Database (Oxford) 2017; 2017.
26.
Lesurf R, Cotto KC, Wang G, Griffith M, Kasaian K, Jones SJ, Montgomery SB, Griffith OL; Open Regulatory Annotation Consortium: oregAnno 3.0: a community-driven resource for curated regulatory annotation. Nucleic Acids Res 2016; 44:D126–D132.
27.
ENCODE Project Consortium: An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57–74.
28.
Sharma S, Kelly TK, Jones PA: Epigenetics in cancer. Carcinogenesis 2010; 31: 27–36.
29.
Ward CJ, Turley H, Ong AC, Comley M, Biddolph S, Chetty R, Ratcliffe PJ, Gattner K, Harris PC: Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci U S A 1996; 93: 1524–1528.
30.
Peters DJ, Spruit L, Klingel R, Prins F, Baelde HJ, Giordano PC, Bernini LF, de Heer E, Breuning MH, Bruijn JA: Adult, fetal, and polycystic kidney expression of polycystin, the polycystic kidney disease-1 gene product. Lab Invest 1996; 75: 221–230.
31.
Palsson R, Sharma CP, Kim K, McLaughlin M, Brown D, Arnaout MA: Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1. Mol Med 1996; 2: 702–711.
32.
Griffin MD, Torres VE, Grande JP, Kumar R: Immunolocalization of polycystin in human tissues and cultured cells. Proc Assoc Am Physicians 1996; 108: 185–197.
33.
Geng L, Segal Y, Peissel B, Deng N, Pei Y, Carone F, Rennke HG, Glucksmann-Kuis AM, Schneider MC, Ericsson M, Reeders ST, Zhou J: Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996; 98: 2674–2682.
34.
Chatterjee A, Rodger EJ, Morison IM, Eccles MR, Stockwell PA: Tools and strategies for analysis of genome-wide and gene-specific DNA methylation patterns. Methods Mol Biol 2017; 1537: 249–277.
35.
Rauch TA, Pfeifer GP: The mira method for DNA methylation analysis. Methods Mol Biol 2009; 507: 65–75.
36.
Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, Gnirke A, Jaenisch R, Lander ES: Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454: 766–770.
37.
Bock C, Tomazou EM, Brinkman AB, Muller F, Simmer F, Gu H, Jager N, Gnirke A, Stunnenberg HG, Meissner A: Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 2010; 28: 1106–1114.
38.
Rauch T, Li H, Wu X, Pfeifer GP: Mira-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res 2006; 66: 7939–7947.
39.
Almamun M, Levinson BT, Gater ST, Schnabel RD, Arthur GL, Davis JW, Taylor KH: Genome-wide DNA methylation analysis in precursor b-cells. Epigenetics 2014; 9: 1588–1595.
40.
Laird PW: Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 2010; 11: 191–203.
41.
Matarese F, Carrillo-de Santa Pau E, Stunnenberg HG: 5-hydroxymethylcytosine: a new kid on the epigenetic block? Mol Syst Biol 2011; 7: 562.
42.
Chu AY, Tin A, Schlosser P, Ko YA, Qiu C, Yao C, Joehanes R, Grams ME, Liang L, Gluck CA, Liu C, Coresh J, Hwang SJ, Levy D, Boerwinkle E, Pankow JS, Yang Q, Fornage M, Fox CS, Susztak K, Kottgen A: Epigenome-wide association studies identify DNA methylation associated with kidney function. Nat Commun 2017; 8: 1286.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.